Trial no.:
|
PACTR202311670817279 |
Date of Approval:
|
16/11/2023 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Cesarean scar pregnancy: a ten-year single center experience |
Official scientific title |
Cesarean scar pregnancy: a ten-year single center experience |
Brief summary describing the background
and objectives of the trial
|
Cesarean scar pregnancy (CSP) is a rare but potentially life-threatening form of ectopic pregnancy which incidence has been constantly raising during the last decades.
The aim of this study was to describe the epidemiological characteristics of CSP in our population and to investigate the impact of different treatments on the maternal outcomes and prognosis.
This was a retrospective study including all patients diagnosed with CSP and who were admitted in our maternity between January 2010 and December 2020. Data were collected from the patients’ medical records. We compared outcomes (hospital stay duration, serum BHCG levels, complications, new pregnancy) in 2 groups: group 1 was treated with systemic injection of methotrexate (MTX) associated with dilatation curettage (DC) and group 2 was managed with uterine artery embolization (UAE) and DC.
|
Type of trial |
Observational |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Obstetrics and Gynecology |
Sub-Disease(s) or condition(s) being studied |
Cesarean scar pregnancy |
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/01/2010 |
Actual trial start date |
01/01/2010 |
Anticipated date of last follow up |
31/12/2020 |
Actual Last follow-up date |
31/12/2020 |
Anticipated target sample size (number of participants) |
1735 |
Actual target sample size (number of participants) |
20 |
Recruitment status |
Completed |
Publication URL |
bardaaoussema@hotmail.fr |
|